Endometrial Polyp Treatment in Manhattan, NY | Kim Gyn
Not every polyp needs to come out right away. The right approach depends on your symptoms, the polyp's size, your fertility goals, and whether you're pre- or postmenopausal.
Key facts
- Not every polyp needs immediate removal. The decision depends on your symptoms, the polyp's size, your fertility goals, and your menopausal status.
- The overall risk that a polyp contains precancerous or cancerous cells is low, about 2.73 percent, but it's roughly 1 percent premenopausal versus about 5 percent postmenopausal.
- Hormonal therapy does not shrink or eliminate existing polyps. It manages bleeding symptoms and can reduce recurrence after removal.
- Hysteroscopic polypectomy, removing the polyp through the cervix with no incisions, is the definitive treatment and the only path to a confirmed pathology diagnosis.
- Polyps can interfere with embryo implantation, and removal before fertility treatment has been shown to improve pregnancy outcomes.
- In postmenopausal women with any bleeding, watchful waiting is not the standard of care.
Which approach is right for you?
Your gynecologist weighs your symptoms, the polyp's size, malignancy risk factors, fertility goals, and menopausal status together. The table below is a starting orientation; full detail on each option is below.
| Option | Best for | Removes the polyp? | Notes |
|---|---|---|---|
| Watchful waiting | Premenopausal, asymptomatic, small polyp under 10mm, no risk factors | No | Repeat ultrasound in 3 to 6 months; some small polyps regress on their own |
| Hormonal management | Managing bleeding symptoms; reducing recurrence after removal | No | Does not eliminate an existing polyp |
| Hysteroscopic polypectomy | Symptomatic polyps, higher-risk patients, fertility treatment planning, any polyp needing tissue diagnosis | Yes | The only approach with a confirmed pathology result |
Considerations before treatment
Not every polyp requires immediate removal. Before recommending a course of action, your gynecologist considers several factors together.
- Symptoms. Polyps causing abnormal bleeding, heavy or irregular periods, bleeding between cycles, or postmenopausal spotting generally warrant treatment. Asymptomatic polyps found incidentally may be candidates for watchful waiting.
- Size. Small polyps under 10 millimeters in asymptomatic premenopausal women have a documented rate of spontaneous regression. Larger polyps, generally above 1 centimeter and especially above 2 to 3 centimeters, are more consistently recommended for removal.
- Risk factors for malignancy. The overall risk is low, about 2.73 percent across all women, but lower premenopausally (about 1 percent) and higher postmenopausally (about 5 percent). Risk rises further with abnormal bleeding, obesity, diabetes, hypertension, or tamoxifen use.
- Fertility status and goals. Women trying to conceive, planning IVF, or with unexplained infertility or implantation failure are routinely recommended for polypectomy before fertility treatment.
- Menopausal status. In postmenopausal women, the threshold for removal is lower, since spontaneous regression is minimal and the risk of pathological findings is higher.
Watchful waiting
For some women, active surveillance without immediate intervention is a clinically appropriate approach, most reasonable when several factors line up together.
Good candidates
- Premenopausal and asymptomatic
- A small polyp, typically under 10 millimeters, identified incidentally
- No significant risk factors for endometrial malignancy
What it involves
- Repeat transvaginal ultrasound at an interval agreed upon with your gynecologist, typically within three to six months
- Prompt re-evaluation if new symptoms develop, including any abnormal bleeding or changes in cycle pattern
- A clear escalation plan: if the polyp grows, persists, or new symptoms arise, removal is the appropriate response
Hormonal management
Hormonal therapy serves two purposes worth distinguishing clearly: it can manage bleeding symptoms, and it can reduce recurrence after surgical removal. What it generally doesn't do is eliminate an existing polyp. There are currently no hormonal medications proven to reliably dissolve an established one.
Levonorgestrel IUD (LNG-IUS)
The option with the most robust evidence. A meta-analysis of 19 randomized trials found it more effective than oral progestin at preventing recurrence after removal, with fewer side effects. Not appropriate if you're actively trying to conceive.
Oral progestins
A secondary preventive option after polypectomy when the LNG-IUS isn't suitable. Their effect on an existing polyp is limited, and they aren't a definitive treatment on their own.
Combined oral contraceptives
May help reduce abnormal bleeding and modestly reduce the risk of new polyp formation. Like progestins, they don't reliably shrink or resolve an established polyp.
Hysteroscopic polypectomy
The definitive treatment for endometrial polyps, recommended for all symptomatic polyps, higher-risk patients, polyps being evaluated before fertility treatment, and any polyp requiring tissue diagnosis.
What the procedure involves
Performed as an outpatient procedure. The hysteroscope passes through the vagina and cervix into the uterine cavity, which is expanded with saline for clear visualization. The polyp is removed using a resectoscope, a tissue removal device such as Aveta, or grasping forceps for smaller, pedunculated polyps. All removed tissue is sent to pathology, a non-negotiable part of the procedure, with results typically returning within one to two weeks.
What to expect after
- Light spotting or discharge in the days following the procedure is normal
- Mild cramping, similar to menstrual cramps, typically responds well to over-the-counter pain relief
- Most women return to desk work and light daily activities within 24 hours
- Intercourse and tampon use are typically restricted for two weeks to allow the uterine lining to heal
- A follow-up appointment reviews pathology results and confirms recovery
Endometrial polyps and fertility
Polyps can interfere with fertility through several mechanisms: they alter the architecture of the uterine cavity, create a local inflammatory environment that may be hostile to an embryo, can mechanically obstruct the fallopian tube openings, and may affect the hormonal signals that regulate endometrial receptivity.
A 2024 study found that after hysteroscopic polypectomy in women with unexplained infertility and at least one prior failed IVF attempt, 72.5 percent achieved a positive pregnancy result in the subsequent cycle. A 2026 review of IVF and ICSI outcomes found clinical pregnancy rates of 53 to 72 percent and live birth rates of 43 to 66 percent following polypectomy. Current clinical guidance favors polypectomy before IVF for symptomatic polyps and those meeting specific clinical criteria, typically performed in the cycle before planned fertility treatment.
Postmenopausal considerations
Postmenopausal polyps do not resolve spontaneously — the hormonal environment that sometimes drives regression in younger women is no longer present. The risk of precancerous or cancerous findings is also meaningfully higher, particularly with abnormal bleeding, rising to approximately 5 percent overall and further with any bleeding. Any postmenopausal bleeding requires thorough evaluation, which includes removal and pathological examination of any identified polyp. Watchful waiting is not the standard of care for a postmenopausal woman with bleeding.